Cell Metab (2016) 24(1):1530
Professor Richard Weller, Professor of Medical Dermatology at the University of Edinburgh and Honorary Consultant Dermatologist, added, Atopic dermatitis, a lifelong condition without a cure, greatly benefits from the expanding range of biologic treatments like lebrikizumab, now reimbursed by NICE, thereby enhancing treatment options for patients. NICEs endorsement of lebrikizumab represents a pivotal development in the treatment landscape for moderate to severe Atopic Dermatitis, offering hope for improved quality of life for many affected individuals.
While effective, they come with notable side effects, including nausea, digestive issues and some serious issues : Vision Impairment Alert Semaglutide, a widely used GLP-1 receptor agonist, has been linked to a significantly higher rate of reported vision problems
in SUSTAIN-6, 1 mg of semaglutide lowered SBP more than the 0.5 mg dose [15]
The MHRA-approved product characteristics provide definitive guidance for each formulation
One study reported that 12 weeks of endurance training significantly improved lower limb and whole-body bone mineral content, as well as whole-body and pelvic BMD in obese participants